NAVANAPHAR

Navana Pharmaceuticals PLC · Pharmaceuticals and Chemicals · Cat A

0/100

High risk

৳72.9

Score breakdown

Technical read

RSI (14)61.3

MACDbearish

Bollingerinside bands (+1.1σ)

Price cycle (Wyckoff)MARKUP

Health trendimproving

Flow pressureneutral

Valuation

Fair value ()

Upside—

Dividend yield+1.90%

Fundamental verdictSUSTAINABLE

Confidence—

Levels

Resistance

৳76.8

৳79.9

৳84.1

৳87.3

Support

৳70.4

৳68.2

৳65.1

৳62.9

Historical bounce zones

May 29, 2025: ৳46.1→৳59.5 +29%

Aug 10, 2025: ৳54.1→৳65.8 +22%

Oct 20, 2025: ৳48.4→৳56.1 +16%

Nov 16, 2025: ৳45.5→৳54.2 +19%

Dec 21, 2025: ৳48.1→৳61.5 +28%

Feb 8, 2026: ৳56.1→৳65.6 +17%

Mar 10, 2026: ৳52→৳60.6 +17%

Apr 6, 2026: ৳55→৳78 +42%

Historical outlook

Based on how similar setups behaved historically — not a prediction of what will happen.

10-day 40% vs 40% market avg Typical move: -5% / -1.2% / 3.6%

30-day 50% vs 42% market avg Typical move: -8.7% / -1.7% / 6.7%

Signals: Bearish Engulfing

Reference levels

Descriptive reference points from the analysis — not instructions to buy or sell.

Entry readAVOID (dormant/dirty)

Reference stopn/a

Reference target—

Timing notestay out

strong artificial activity (score 269); speculative profile — not core-quality. Phase: DORMANT (25% >200-MA, flow neut) -> watch. Elevated sharp-fall risk 9%. ⚠ SOLVENCY DISTRESS (Altman Z 1.05, DETERIORATING) — bankruptcy risk. high-risk. [fundamentals SUSTAINABLE, payout 31.0%, yield 1.9%]